New York Attorney General Eric T. Schneiderman has announced that federal and state government officials have reached a $612 million agreement with Amgen. The company was accused of marketing for unapproved uses of its drugs, as well as manipulating pricing.

The money goes to compensate Medicaid, Medicare and various federal health care programs for harm suffered as a result of Amgen’s conduct. The company also has to pay $150 million in fines and forfeitures to federal authorities for criminal conduct.

Amgen, the company behind drugs such as psoriasis medication Enbrel, is based in Thousand Oaks, Calif.

Lauren Ohnesorge covers information technology and entrepreneurship.

Industries:

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.